Cargando…
MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
BACKGROUND: Biomarkers are needed to improve current diagnosis and surveillance strategies for patients with Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC). Macrophage inhibitory cytokine 1/growth differentiation factor 15 (MIC-1/GDF15) tissue and plasma levels have been shown t...
Autores principales: | Fisher, O M, Levert-Mignon, A J, Lord, S J, Lee-Ng, K K M, Botelho, N K, Falkenback, D, Thomas, M L, Bobryshev, Y V, Whiteman, D C, Brown, D A, Breit, S N, Lord, R V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402450/ https://www.ncbi.nlm.nih.gov/pubmed/25867265 http://dx.doi.org/10.1038/bjc.2015.100 |
Ejemplares similares
-
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett’s Esophagus and Adenocarcinoma
por: Fisher, Oliver M., et al.
Publicado: (2014) -
Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016) -
Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003) -
Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011) -
Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus
por: Dunn, J M, et al.
Publicado: (2011)